Acute coronary syndromes (ACS) are the most common cause of mortality and morbidity worldwide. Implementing time-sensitive therapies and maximizing outcomes depend on the clinical separation of acute myocardial infarction (MI) from unstable angina and other presentations mimicking ACS. However, the diagnostic procedures rely on blood tests and the turnaround times in the laboratory.
In a recent research published in the European Heart Journal – Digital Health, a team of researchers tested the clinical viability of a wrist-worn transdermal infrared spectrophotometric sensor transdermal-infrared spectrophotometric sensor (transdermal-ISS) in real-world clinical settings in predicting high troponin-I levels in patients with ACS. The troponin-I sensor was assessed in hospitalized ACS patients with matched venous blood drawn for a centralized troponin-I assay. It was found that for quick,…
